|
1
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
4
|
Altman BJ and Rathmell JC: Metabolic
stress in autophagy and cell death pathways. Cold Spring Harb
Perspect Biol. 4:a0087632012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kovaleva V, Mora R, Park YJ, et al:
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and
trigger killing of chronic lymphocytic leukemia cells. Cancer Res.
72:1763–1772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuma A, Hatano M, Matsui M, et al: The
role of autophagy during the early neonatal starvation period.
Nature. 432:1032–1036. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: a double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo JY, Karsli-Uzunbas G, Mathew R, et al:
Autophagy suppresses progression of K-ras-induced lung tumors to
oncocytomas and maintains lipid homeostasis. Genes Dev.
27:1447–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie Z and Klionsky DJ: Autophagosome
formation: core machinery and adaptations. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Z and Klionsky DJ: Mammalian
autophagy: core molecular machinery and signaling regulation. Curr
Opin Cell Biol. 22:124–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Velikkakath AK, Nishimura T, Oita E,
Ishihara N and Mizushima N: Mammalian Atg2 proteins are essential
for autophagosome formation and important for regulation of size
and distribution of lipid droplets. Mol Biol Cell. 23:896–909.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Flynt AS and Lai EC: Biological principles
of microRNA-mediated regulation: shared themes amid diversity. Nat
Rev Genet. 9:831–842. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ventura A and Jacks T: MicroRNAs and
cancer: short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frankel LB and Lund AH: MicroRNA
regulation of autophagy. Carcinogenesis. 33:2018–2025. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhai H, Fesler A and Ju J: MicroRNA: a
third dimension in autophagy. Cell Cycle. 12:246–250. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang R, Xiao T, Fang Z, et al:
MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting
hexokinase 2 gene. J Biol Chem. 287:23227–23235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Q, Jiang Q, Pu Q, et al: MicroRNA-143
inhibits migration and invasion of human non-small-cell lung cancer
and its relative mechanism. Int J Biol Sci. 9:680–692. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qian X, Yu J, Yin Y, et al: MicroRNA-143
inhibits tumor growth and angiogenesis and sensitizes
chemosensitivity to oxaliplatin in colorectal cancers. Cell Cycle.
12:1385–1394. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Ou Y, Wu K, Chen Y and Sun W:
miR-143 inhibits the metastasis of pancreatic cancer and an
associated signaling pathway. Tumor Biology. 33:1863–1870. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gregersen LH, Jacobsen A, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-143 down-regulates Hexokinase 2 in
colon cancer cells. BMC Cancer. 12:2322012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song T, Zhang X, Wang C, et al: Expression
of miR-143 reduces growth and migration of human bladder carcinoma
cells by targeting cyclooxygenase-2. Asian Pac J Cancer Prev.
12:929–933. 2011.PubMed/NCBI
|
|
24
|
Jiang S, Zhang LF, Zhang HW, et al: A
novel miR-155/miR-143 cascade controls glycolysis by regulating
hexokinase 2 in breast cancer cells. EMBO J. 31:1985–1998. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ni Y, Meng L, Wang L, et al: MicroRNA-143
functions as a tumor suppressor in human esophageal squamous cell
carcinoma. Gene. 517:197–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
27
|
Pan X, Zhang X, Sun H, Zhang J, Yan M and
Zhang H: Autophagy inhibition promotes 5-fluorouraci-induced
apoptosis by stimulating ROS formation in human non-small cell lung
cancer A549 cells. PLoS One. 8:e566792013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mathupala SP, Ko YH and Pedersen PL:
Hexokinase-2 bound to mitochondria: Cancer’s stygian link to the
‘Warburg effect’ and a pivotal target for effective therapy. Semin
Cancer Biol. 19:17–24. 2009.
|
|
30
|
Yoshino H, Enokida H, Itesako T, et al:
Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in
renal cell carcinoma. Cancer Sci. 104:1567–1574. 2013. View Article : Google Scholar : PubMed/NCBI
|
